These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 19054788)

  • 1. Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devices.
    Duray GZ; Schmitt J; Cicek-Hartvig S; Hohnloser SH; Israel CW
    Europace; 2009 Mar; 11(3):297-302. PubMed ID: 19054788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necessity for surgical revision of defibrillator leads implanted long-term: causes and management.
    Eckstein J; Koller MT; Zabel M; Kalusche D; Schaer BA; Osswald S; Sticherling C
    Circulation; 2008 May; 117(21):2727-33. PubMed ID: 18490526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biventricular defibrillator patients have higher complication rates after revision of recalled leads.
    Brumberg GE; Kaseer B; Shah H; Saba S; Jain S
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):665-71. PubMed ID: 22519559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inappropriate ICD discharges in single-chamber versus dual-chamber devices in the pediatric and young adult population.
    Lawrence D; Von Bergen N; Law IH; Bradley DJ; Dick M; Frias PA; Streiper MJ; Fischbach PS
    J Cardiovasc Electrophysiol; 2009 Mar; 20(3):287-90. PubMed ID: 19175843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of implantable defibrillator longevity under clinical circumstances: implications for device selection.
    Knops P; Theuns DA; Res JC; Jordaens L
    Pacing Clin Electrophysiol; 2009 Oct; 32(10):1276-85. PubMed ID: 19796344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial.
    Almendral J; Arribas F; Wolpert C; Ricci R; Adragao P; Cobo E; Navarro X; Quesada A; ; ;
    Europace; 2008 May; 10(5):528-35. PubMed ID: 18390985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience and procedural outcomes associated with the DF4 implantable cardioverter defibrillator system: the SJ4 postapproval study.
    Cantillon DJ; Ha K; Styperek R; Jumrussirikul P; Mirro M; Wong W; Wilkoff BL
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):855-62. PubMed ID: 23617316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry.
    Poole JE; Gleva MJ; Mela T; Chung MK; Uslan DZ; Borge R; Gottipaty V; Shinn T; Dan D; Feldman LA; Seide H; Winston SA; Gallagher JJ; Langberg JJ; Mitchell K; Holcomb R;
    Circulation; 2010 Oct; 122(16):1553-61. PubMed ID: 20921437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of redo procedures in patients with an implantable cardioverter-defibrillator--long-term follow-up results.
    Gepner K; Przybylski A; Maciag A; Sterliński M; Lewandowski M; Syska P; Kowalik I; Szwed H
    Kardiol Pol; 2007 Aug; 65(8):893-8; discussion 899. PubMed ID: 17853318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world data on the lifespan of implantable cardioverter-defibrillators depending on manufacturers and the amount of ventricular pacing.
    Horlbeck FW; Mellert F; Kreuz J; Nickenig G; Schwab JO
    J Cardiovasc Electrophysiol; 2012 Dec; 23(12):1336-42. PubMed ID: 22909190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications associated with generator replacement in response to device advisories.
    Costea A; Rardon DP; Padanilam BJ; Fogel RI; Prystowsky EN
    J Cardiovasc Electrophysiol; 2008 Mar; 19(3):266-9. PubMed ID: 18081773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Explantation of implantable defibrillator leads using open heart surgery or percutaneous techniques.
    Camboni D; Wollmann CG; Löher A; Gradaus R; Scheld HH; Schmid C
    Ann Thorac Surg; 2008 Jan; 85(1):50-5. PubMed ID: 18154777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The innominate vein as alternative venous access for complicated implantable cardioverter defibrillator revisions.
    Aleksic I; Kottenberg-Assenmacher E; Kienbaum P; Szabo AK; Sommer SP; Wieneke H; Yildirim C; Leyh RG
    Pacing Clin Electrophysiol; 2007 Aug; 30(8):957-60. PubMed ID: 17669077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences.
    Nery PB; Fernandes R; Nair GM; Sumner GL; Ribas CS; Menon SM; Wang X; Krahn AD; Morillo CA; Connolly SJ; Healey JS
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):786-90. PubMed ID: 20102431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.
    Palmisano P; Accogli M; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S
    Europace; 2013 Apr; 15(4):531-40. PubMed ID: 23407627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients.
    Alter P; Waldhans S; Plachta E; Moosdorf R; Grimm W
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):926-32. PubMed ID: 16176531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators.
    Kolb C; Deisenhofer I; Schmieder S; Barthel P; Zrenner B; Karch MR; Schmitt C
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):946-52. PubMed ID: 16981917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should all dysfunctional high-voltage leads be extracted? Results of a single-centre long-term registry.
    Bode F; Himmel F; Reppel M; Mortensen K; Schunkert H; Wiegand UK
    Europace; 2012 Dec; 14(12):1764-70. PubMed ID: 22753865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of manufacturer advisories and FDA recalls of implantable cardioverter defibrillator generators in pediatric and congenital heart disease patients.
    Mahajan T; Dubin AM; Atkins DL; Bradley DJ; Shannon KM; Erickson CC; Franklin WH; Cecchin F; Berul CI;
    J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1270-4. PubMed ID: 18691353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.